Is Ozempic a Peptide Shot? Everything You Need to Know

Last reviewed: June 20, 2026

Last updated: June 20, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Ozempic contains semaglutide, a synthetic compound that activates GLP-1 receptors—the same pathway natural appetite-regulating peptides use in your body. While Ozempic itself isn't a peptide, it works like one, making the distinction mostly technical. Understanding this difference matters when exploring affordable alternatives for weight loss and metabolic health.

What Exactly Is Ozempic and How Does It Work

Ozempic is a prescription medication containing semaglutide, manufactured by Novo Nordisk. Semaglutide is not a peptide but rather a small organic compound designed to mimic the action of glucagon-like peptide-1 (GLP-1), a natural hormone your intestines release after eating. When semaglutide binds to GLP-1 receptors on cells throughout your brain, pancreas, and digestive system, it slows stomach emptying, increases feelings of fullness, and helps regulate blood sugar levels.

The FDA approved Ozempic in 2017 for type 2 diabetes management, and later approved the higher-dose version Wegovy in 2021 for chronic weight management in adults with obesity or overweight with weight-related conditions. Clinical trials showed participants lost 5–15% of their body weight over 68 weeks depending on the dose. The medication has become widely prescribed off-label for weight loss, driving demand and creating supply shortages that have affected patient access and insurance coverage.

Peptides vs. GLP-1 Agonists: Understanding the Chemistry

Peptides are chains of amino acids, and true peptide GLP-1 agonists do exist—the original GLP-1 hormone is itself a peptide with 30 amino acids. However, semaglutide (the active ingredient in Ozempic and Wegovy) is a non-peptide small molecule with a longer half-life and better oral bioavailability than natural GLP-1. This chemical modification allows semaglutide to stay in your bloodstream longer and work more effectively across different tissues.

Tirzepatide, another popular GLP-1 receptor agonist found in Mounjaro and Zepbound, is also a non-peptide compound. Both semaglutide and tirzepatide achieve weight loss and metabolic benefits by triggering the same GLP-1 signaling pathways that peptide hormones naturally activate, making the peptide-versus-agonist distinction less important clinically than efficacy and individual response.

Why Compounded Semaglutide May Be Right for You

PlexusDx partners with licensed 503A compounding pharmacies to provide compounded semaglutide injections at $189/mo month-to-month, or from $149/mo on the 6-month plan—significantly lower than brand-name Ozempic, which often costs $900–$1,300 per month before insurance. Compounded semaglutide contains the same active ingredient as Ozempic but is prepared by licensed pharmacists rather than mass-manufactured by a pharmaceutical company. Both forms activate GLP-1 receptors identically and produce comparable weight loss outcomes in clinical use.

PlexusDx serves all 50 states without requiring insurance, membership fees, or prior authorization delays. Your dose may need to increase over time as your body builds tolerance, but your monthly price remains flat—never scaling with dosage adjustments. HSA and FSA accounts are accepted, offering additional tax-advantaged savings on your treatment.

Personalized Treatment: The Precision Peptide Genetic Test Advantage

Not everyone responds equally to GLP-1 agonists. Your genetic makeup influences how effectively semaglutide engages GLP-1 receptors and how your body processes the medication. PlexusDx offers the Precision Peptide Genetic Test, a $298, which analyzes key genetic variants including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 across 14 metabolic pathways.

The PlexusDx Precision Peptide Genetic Test reports on variants that relate to GLP-1 and related signaling pathways. It does not predict your response to semaglutide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test ($298) to personalize your protocol from day one.

Frequently Asked Questions

Is Ozempic technically a peptide shot?

No—Ozempic contains semaglutide, a non-peptide small molecule that mimics the action of GLP-1, a natural peptide hormone. While not a peptide itself, semaglutide activates the same GLP-1 receptors that peptide signaling does, making the distinction mostly chemical rather than functional.

How does compounded semaglutide from PlexusDx compare to brand-name Ozempic?

Compounded semaglutide from PlexusDx is prepared by licensed 503A pharmacies and contains the identical active ingredient as Ozempic. The main differences are cost (starting at $149/month vs. $900–$1,300 for Ozempic) and convenience—no insurance required, no authorization delays, and nationwide availability.

Why does my GLP-1 dose need to increase over time?

Your body adapts to medications through a process called tachyphylaxis, reducing the drug's initial effect. GLP-1 therapy typically begins at low doses and gradually increases every 4 weeks until you reach your therapeutic dose or experience optimal appetite suppression. PlexusDx keeps your monthly price flat throughout this escalation—your dose goes up, your price won't.

What side effects should I expect from semaglutide injections?

Common side effects include mild nausea, vomiting, diarrhea, and constipation, especially during the first 2–4 weeks. Most side effects diminish as your body adjusts. Serious side effects are rare but include pancreatitis (severe abdominal pain) and gallbladder issues. Always report persistent symptoms to your PlexusDx clinician.

How does the Precision Peptide Genetic Test improve my treatment outcomes?

The test identifies your genetic predispositions across 14 peptide pathways and 49 metabolic peptides, revealing how your body will likely respond to semaglutide dosing. This guides clinicians to optimize your starting dose and escalation schedule, potentially accelerating weight loss and reducing the trial-and-error phase of treatment.

Related Reading

• Genetic Testing 101 What You Need To Know Before Getting Tested
• Ozempic Shot
• Test Before You Invest Peptide Protocols
• What Is Genetic Peptide Testing And Why It Matters Before You Start A Protocol

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.